Почетна › Ulcerativni kolitis › Вашингтон
Kliničke studije za Ulcerativni kolitis u državi Вашингтон
19 studija za Ulcerativni kolitis traži učesnike na lokacijama u državi Вашингтон.
Gradovi u državi Вашингтон
Zvanični tekst studije (na engleskom)
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-021, Bellevue
- Site US-029, Tacoma
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 12. 11. 2026. · NCT07845487A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
- University of Washington, Seattle
- Digestive Health Specialists, Tacoma
Тражи се учесникФаза 2
Узраст од 18 до 80 · Оба пола · Ажурирано 12. 11. 2026. · NCT06636656Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- Washington Gastroenterology - Tacoma ( Site 0295), Tacoma
Тражи се учесникФаза 3
Сви узрасти · Оба пола · Ажурирано 10. 11. 2026. · NCT06651281LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Swedish Medical Center, Seattle
- Principle Research Solutions, Spokane
- Providence Sacred Heart Medical Center & Children's Hospital, Spokane
- и још 1
Тражи се учесникФаза 2
Узраст од 18 до 80 · Оба пола · Ажурирано 4. 11. 2026. · NCT07415044Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Washington Gastroenterology - Tacoma, Tacoma
Тражи се учесникФаза 3
Узраст од 18 до 70 · Оба пола · Ажурирано 4. 11. 2026. · NCT06937086LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Washington Gastroenterology - Bellevue, Bellevue
Тражи се учесникФаза 2
Узраст од 18 до 80 · Оба пола · Ажурирано 4. 11. 2026. · NCT07186101A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- GI Alliance Tacoma, Tacoma
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07577856A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- GI Alliance, Bellevue
Тражи се учесникФаза 4
Узраст од 18 до 80 · Оба пола · Ажурирано 28. 10. 2026. · NCT06581328Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Washington Gastroenterology - Bellevue /ID# 283966, Bellevue
- Washington Gastroenterology - Tacoma /ID# 284143, Tacoma
- The Vancouver Clinic /ID# 280497, Vancouver
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 27. 10. 2026. · NCT07697456A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 004, Seattle
- Site 019, Tacoma
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 27. 10. 2026. · NCT07012395An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
- Washington Gastroenterology, Tacoma
Тражи се учесникОпсервациона студија
Узраст од 18 до 64 · Оба пола · Ажурирано 26. 10. 2026. · NCT06398626An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- GI Alliance - Bellevue - Site Number: 8400143, Bellevue
- The Vancouver Clinic Inc. P.S. - Site Number: 8400090, Vancouver
Тражи се учесникФаза 3
Узраст од 16 до 80 · Оба пола · Ажурирано 23. 10. 2026. · NCT07184996A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Seattle Children's Hospital, Seattle
- MultiCare Health System, Tacoma
Тражи се учесникФаза 2/3
Узраст од 2 до 17 · Оба пола · Ажурирано 20. 10. 2026. · NCT05076175A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- The Vancouver Clinic Inc. P.S. - Site Number: 8400090, Vancouver
Тражи се учесникФаза 3
Узраст од 16 до 80 · Оба пола · Ажурирано 16. 10. 2026. · NCT07185009A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Multicare Health System Institute for Research and Innovation, Tacoma
Тражи се учесникФаза 3
Узраст од 2 до 17 · Оба пола · Ажурирано 9. 10. 2026. · NCT06405087Familial Inflammatory Bowel Disease Early Risk
- Seattle Children's Hospital, Seattle
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 0 до 55 · Оба пола · Ажурирано 28. 8. 2026. · NCT07791862A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
- MultiCare Institute for Research & Innovation, Tacoma
Тражи се учесникФаза 3
Узраст од 2 до 17 · Оба пола · Ажурирано 3. 8. 2026. · NCT06100289Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)
- Seattle Children's Hospital, Seattle
Тражи се учесникОпсервациона студија
Узраст од 6 до 21 · Оба пола · Ажурирано 24. 4. 2026. · NCT06315179A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Bellevue
- Mirador Therapeutics Selected Site, Silverdale
- Mirador Therapeutics Selected Site, Tacoma
Тражи се учесникФаза 2
Узраст од 18 до 80 · Оба пола · Ажурирано 12. 3. 2026. · NCT07113522Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.